Award-Winning Evolve Formulas Transdermal NanoSerum™ To Hit Dispensary Shelves in the Golden State in Time for the Holidays
DENVER (October 10, 2018) – NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, in partnership with Vertical™, the largest fully integrated company in the legal medical cannabis industry, has officially started production to bring its commercial cannabis brand, Evolve Formulas, into the California market.
As the national dialogue surrounding cannabis continues to shift in favor of legalization, public knowledge of the plant’s health and wellness benefits is spreading, with many patients of mental illness discovering the potential of cannabis to relieve psychological distress and restore their ability to function in day-to-day life.
DENVER (September 11, 2018) – NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, has entered into a revenue-sharing agreement to expand its Evolve Formulas product line to Indiana with Jeff DeHart, Managing Member of Evolve Formulas of Indiana, LLC. Under the agreement, NanoSphere will introduce a new, hemp-derived offering to the Indiana market.
CEO Robert Sutton Recognized as Gamechanger of the Year; NanoSphere Named Company of the Year for Nano-Biotechnology and Innovative Company of the Year for Healthcare
DENVER (August 21, 2018) – NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), the nano-biotechnology company that has commercialized a patented delivery system known as the NanoSphere Delivery System™, has won three 2018 Global Awards from ACQ5, a premier global corporate magazine.
Since our last update in April 2018, we have seen significant milestones for NanoSphere Health Sciences. We began the second quarter by announcing new licensing agreements to expand our Evolve Formulas brand into California and Arizona, followed by winning a prestigious award for technological innovation from Frost & Sullivan and retaining Gravitas Securities Inc as financial advisors.